January 2020 FDA Recall Netspot by Advanced Accelerator Applications Usa, Inc.
D-0799-2020 - Defective Container

This Class II drug recall was voluntarily initiated by Advanced Accelerator Applications Usa, Inc. on January 10, 2020 for the product Netspot. The FDA reported the reason for recall as defective container. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0799-2020

Reason for Recall
Defective Container: loose aluminum cap crimp for the dilution buffer vial present in the NETSPOT Kit (vial 2).
Initiated
01-10-2020
Reported
01-29-2020
Quantity
4295 Kits

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Advanced Accelerator Applications USA, Inc.
Nationwide in the US and Canada
NETSPOT, (kit for the preparation of Ga 68 dotatate injection) 40 mcg dotatate, For Intravenous Use Only, Rx Only, Manufactured for: Advanced Accelerator Applications USA, Inc. by Gipharma S.r.l. Strada Crescentino snc, 13040 Saluggia (Vc), Italy, NDC 69488-001-40.

Batch or Lot Expiration Information

Lot# : PG1919025, Exp. 07/11/2020; PG1919026, PG1919027, Exp. 07/16/2020.

Affected Packages Involved in this Recall